{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:31:57Z","timestamp":1793316717561,"version":"4.5.0"},"reference-count":39,"publisher":"MDPI AG","issue":"23","license":[{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Science and Technology Council","award":["NSTC 112-2321-B-195-001"],"award-info":[{"award-number":["NSTC 112-2321-B-195-001"]}]},{"name":"National Science and Technology Council","award":["NSTC 114-2321-B-195-001"],"award-info":[{"award-number":["NSTC 114-2321-B-195-001"]}]},{"DOI":"10.13039\/501100004861","name":"Mackay Memorial Hospital","doi-asserted-by":"publisher","award":["MMH-114- 82"],"award-info":[{"award-number":["MMH-114- 82"]}],"id":[{"id":"10.13039\/501100004861","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background\/Objectives: Chemotherapy-induced adverse events significantly impact cancer treatment outcomes and patient quality of life. Emerging evidence suggests that gut microbiota composition may influence individual susceptibility to chemotherapy toxicity. This study investigated associations between gut microbiome alterations and specific chemotherapy-related adverse events in breast cancer patients undergoing cancer treatment. Methods: We conducted a prospective cohort study of 81 breast cancer patients receiving chemotherapy between May 2018 and October 2022. Gut microbiome composition was analyzed using 16S rRNA sequencing across multiple taxonomic levels. Alpha diversity (Chao1 estimator) and beta diversity (PERMANOVA) analyses were performed to assess microbial richness and community structure. Linear discriminant analysis effect size (LEfSe) identified differentially abundant taxa, with Cohen\u2019s d effect sizes calculated with 95% confidence intervals and false discovery rate correction applied for multiple comparisons. Results: Significant microbiome-toxicity associations were identified across 42 taxa (FDR q &lt; 0.05, effect sizes d = \u22121.60 to +1.67). Severe anemia demonstrated the strongest associations, with large effect size enrichment of Eubacteriaceae (d = 1.38), Anaerofilum (d = 1.42), and Eubacterium (d = 1.38). Severe neutropenia was characterized by depletion of butyrate-producing bacteria, particularly Eubacterium_hallii_group (d = \u22121.08). Thrombocytopenia showed dramatic depletion of Eubacterium limosum (53-fold reduction, d = \u22121.60). Hepatotoxicity (ALT elevation) was associated with depletion of Eubacterium_hallii_group (d = \u22120.99) and Burkholderia-Caballeronia-Paraburkholderia (d = \u22121.19). Hand-foot syndrome exhibited significantly elevated microbial diversity with depletion of Lachnospiraceae taxa. Most adverse events showed enrichment rather than depletion patterns, with 54.8% of significant associations demonstrating medium to large effect sizes. Conclusions: Specific gut microbiota signatures associated with distinct chemotherapy-related adverse events, suggesting potential microbiome-based biomarkers for toxicity prediction and personalized cancer treatment strategies.<\/jats:p>","DOI":"10.3390\/cancers17233783","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T13:56:34Z","timestamp":1764165394000},"page":"3783","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Gut Microbiota Signatures Associate with Chemotherapy-Related Adverse Events in Breast Cancer Patients"],"prefix":"10.3390","volume":"17","author":[{"given":"Jiun-Wei","family":"Hsu","sequence":"first","affiliation":[{"name":"Department of General Surgery, MacKay Memorial Hospital, Taipei 104217, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3958-4202","authenticated-orcid":false,"given":"Ying-Wen","family":"Su","sequence":"additional","affiliation":[{"name":"Department of Medicine, Mackay Medical University, New Taipei 252005, Taiwan"},{"name":"Department of Medical Oncology, MacKay Memorial Hospital, Taipei 104217, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung-Hsin","family":"Tsai","sequence":"additional","affiliation":[{"name":"Department of General Surgery, MacKay Memorial Hospital, Taipei 104217, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Chan","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of General Surgery, MacKay Memorial Hospital, Taipei 104217, Taiwan"},{"name":"Department of Medicine, Mackay Medical University, New Taipei 252005, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5753-1177","authenticated-orcid":false,"given":"Horng-Woei","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Medical Research, MacKay Memorial Hospital, New Taipei City 251404, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie-Jen","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of General Surgery, MacKay Memorial Hospital, Taipei 104217, Taiwan"},{"name":"Department of Medicine, Mackay Medical University, New Taipei 252005, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsi-Hsien","family":"Hsu","sequence":"additional","affiliation":[{"name":"Department of Colorectal Surgery, MacKay Memorial Hospital, Taipei 104217, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of General Surgery, MacKay Memorial Hospital, Taipei 104217, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6226-2618","authenticated-orcid":false,"given":"Po-Sheng","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of General Surgery, MacKay Memorial Hospital, Taipei 104217, Taiwan"},{"name":"Department of Medicine, Mackay Medical University, New Taipei 252005, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,11,26]]},"reference":[{"key":"ref_1","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"S142","DOI":"10.3747\/co.25.3954","article-title":"Advances in the systemic treatment of triple-negative breast cancer","volume":"25","author":"Lebert","year":"2018","journal-title":"Curr. Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s10549-020-05809-w","article-title":"Use of neoadjuvant versus adjuvant chemotherapy for hormone receptor-positive breast cancer: A National Cancer Database (NCDB) study","volume":"184","author":"Zeidman","year":"2020","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1245\/s10434-018-6531-5","article-title":"Neoadjuvant Chemotherapy Use in Breast Cancer is Greatest in Excellent Responders: Triple-Negative and HER2+ Subtypes","volume":"25","author":"Murphy","year":"2018","journal-title":"Ann. Surg. Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"119","DOI":"10.4048\/jbc.2017.20.2.119","article-title":"Recent Advances in the Neoadjuvant Treatment of Breast Cancer","volume":"20","author":"Rubovszky","year":"2017","journal-title":"J. Breast Cancer"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.cpet.2018.02.006","article-title":"Overview of Breast Cancer Therapy","volume":"13","author":"Moo","year":"2018","journal-title":"PET Clin."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/FPC.0b013e32833ffb56","article-title":"Doxorubicin pathways: Pharmacodynamics and adverse effects","volume":"21","author":"Thorn","year":"2011","journal-title":"Pharmacogenet Genom."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/bs.acr.2022.02.007","article-title":"Chemotherapy induced gastrointestinal toxicities","volume":"155","author":"Akbarali","year":"2022","journal-title":"Adv. Cancer Res."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1038\/s41418-021-00784-1","article-title":"Intestinal microbiota influences clinical outcome and side effects of early breast cancer treatment","volume":"28","author":"Terrisse","year":"2021","journal-title":"Cell Death Differ."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/nature09944","article-title":"Enterotypes of the human gut microbiome","volume":"473","author":"Arumugam","year":"2011","journal-title":"Nature"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Fernandez, M.F., Reina-Perez, I., Astorga, J.M., Rodriguez-Carrillo, A., Plaza-Diaz, J., and Fontana, L. (2018). Breast Cancer and Its Relationship with the Microbiota. Int. J. Environ. Res. Public Health, 15.","DOI":"10.3390\/ijerph15081747"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/PPO.0000000000000048","article-title":"Microbiome, inflammation, and cancer","volume":"20","author":"Francescone","year":"2014","journal-title":"Cancer J."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/nrc3610","article-title":"The microbiome and cancer","volume":"13","author":"Schwabe","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41591-019-0406-6","article-title":"Meta-analysis of fecal metagenomes reveals global microbial signatures that are specific for colorectal cancer","volume":"25","author":"Wirbel","year":"2019","journal-title":"Nat. Med."},{"key":"ref_15","first-page":"5812","article-title":"The interaction between gut microbiome and anti-tumor drug therapy","volume":"11","author":"Fu","year":"2021","journal-title":"Am. J. Cancer Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/s41586-021-03891-8","article-title":"Bioaccumulation of therapeutic drugs by human gut bacteria","volume":"597","author":"Klunemann","year":"2021","journal-title":"Nature"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1158\/0008-5472.CAN-20-1659","article-title":"Gut Microbiota Condition the Therapeutic Efficacy of Trastuzumab in HER2-Positive Breast Cancer","volume":"81","author":"Gargari","year":"2021","journal-title":"Cancer Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1126\/science.aan3706","article-title":"Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors","volume":"359","author":"Routy","year":"2018","journal-title":"Science"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Li, Y., Dong, B., Wu, W., Wang, J., Jin, H., Chen, K., Huang, K., Huang, S., and Yao, Y. (2022). Metagenomic Analyses Reveal Distinct Gut Microbiota Signature for Predicting the Neoadjuvant Chemotherapy Responsiveness in Breast Cancer Patients. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.865121"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1158\/1541-7786.MCR-19-0451","article-title":"Neoadjuvant Chemotherapy Shifts Breast Tumor Microbiota Populations to Regulate Drug Responsiveness and the Development of Metastasis","volume":"18","author":"Chiba","year":"2020","journal-title":"Mol. Cancer Res."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Cray, P., Sheahan, B.J., Cortes, J.E., and Dekaney, C.M. (2020). Doxorubicin increases permeability of murine small intestinal epithelium and cultured T84 monolayers. Sci. Rep., 10.","DOI":"10.1038\/s41598-020-78473-1"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1002\/cncr.35229","article-title":"Gut microbiome in association with chemotherapy-induced toxicities among patients with breast cancer","volume":"130","author":"Nguyen","year":"2024","journal-title":"Cancer"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Singh, A., Alexander, S.G., and Martin, S. (2023). Gut microbiome homeostasis and the future of probiotics in cancer immunotherapy. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1114499"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0167-7012(02)00260-9","article-title":"Evaluation of QIAamp DNA Stool Mini Kit for ecological studies of gut microbiota","volume":"54","author":"Li","year":"2003","journal-title":"J. Microbiol. Methods"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/nar\/gks808","article-title":"Evaluation of general 16S ribosomal RNA gene PCR primers for classical and next-generation sequencing-based diversity studies","volume":"41","author":"Klindworth","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/s41587-019-0209-9","article-title":"Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2","volume":"37","author":"Bolyen","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"5069","DOI":"10.1128\/AEM.03006-05","article-title":"Greengenes, a chimera-checked 16S rRNA gene database and workbench compatible with ARB","volume":"72","author":"DeSantis","year":"2006","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Segata, N., Izard, J., Waldron, L., Gevers, D., Miropolsky, L., Garrett, W.S., and Huttenhower, C. (2011). Metagenomic biomarker discovery and explanation. Genome Biol., 12.","DOI":"10.1186\/gb-2011-12-6-r60"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1136\/gutjnl-2016-313432","article-title":"Recovery of ethanol-induced Akkermansia muciniphila depletion ameliorates alcoholic liver disease","volume":"67","author":"Grander","year":"2018","journal-title":"Gut"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/nm.4236","article-title":"A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice","volume":"23","author":"Plovier","year":"2017","journal-title":"Nat. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"3655","DOI":"10.1128\/AEM.04050-14","article-title":"Akkermansia muciniphila Adheres to Enterocytes and Strengthens the Integrity of the Epithelial Cell Layer","volume":"81","author":"Reunanen","year":"2015","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1038\/s41591-019-0495-2","article-title":"Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: A proof-of-concept exploratory study","volume":"25","author":"Depommier","year":"2019","journal-title":"Nat. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1136\/gutjnl-2012-303839","article-title":"An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice","volume":"63","author":"Shin","year":"2014","journal-title":"Gut"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"9066","DOI":"10.1073\/pnas.1219451110","article-title":"Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity","volume":"110","author":"Everard","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Xu, Y., Wang, N., Tan, H.Y., Li, S., Zhang, C., and Feng, Y. (2020). Function of Akkermansia muciniphila in Obesity: Interactions With Lipid Metabolism, Immune Response and Gut Systems. Front. Microbiol., 11.","DOI":"10.3389\/fmicb.2020.00219"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1111\/1751-7915.13410","article-title":"Akkermansia muciniphila is a promising probiotic","volume":"12","author":"Zhang","year":"2019","journal-title":"Microb. Biotechnol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"5810","DOI":"10.1128\/AEM.70.10.5810-5817.2004","article-title":"Lactate-utilizing bacteria, isolated from human feces, that produce butyrate as a major fermentation product","volume":"70","author":"Duncan","year":"2004","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.mib.2013.06.003","article-title":"Faecalibacterium prausnitzii and human intestinal health","volume":"16","author":"Miquel","year":"2013","journal-title":"Curr. Opin. Microbiol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/s41467-017-00796-x","article-title":"Gastric acid suppression promotes alcoholic liver disease by inducing overgrowth of intestinal Enterococcus","volume":"8","author":"Llorente","year":"2017","journal-title":"Nat. Commun."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/23\/3783\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T05:12:03Z","timestamp":1764393123000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/23\/3783"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,26]]},"references-count":39,"journal-issue":{"issue":"23","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["cancers17233783"],"URL":"https:\/\/doi.org\/10.3390\/cancers17233783","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,26]]}}}